Skip to main content
. 2020 Sep 3;63(11):2396–2409. doi: 10.1007/s00125-020-05257-7

Table 1.

Characteristics of study participants

Participant group n (male/female) Age (years) (mean ± SD) Range (years) T1D duration (mean ± SD) Range
Paediatric T1D 51 (25/26) 8.6 ± 3.9 2–15 <1 week N/A
Paediatric AAb+ 27 (14/13) 8.6 ± 4.5 2–15 N/A N/A
 Progressors 11 (6/5) 7.7 ± 4.5 2–13 N/A N/A
 Nonprogressors 16 (8/8) 9.0 ± 4.5 2–15 N/A N/A
Paediatric control 113 (64/49) 8.9 ± 3.9 2–15 N/A N/A
Adult T1D 33 (19/14) 27.1 ± 6.4 19–39 11.9 ± 8.0 y 0.4–30 y
Adult control 37 (14/23) 26.2 ± 4.4 20–38 N/A N/A

N/A, not applicable; T1D, type 1 diabetes; y, years